GB1129393A - Tetrazolyl alkanoic acids - Google Patents
Tetrazolyl alkanoic acidsInfo
- Publication number
- GB1129393A GB1129393A GB54597/66A GB5459766A GB1129393A GB 1129393 A GB1129393 A GB 1129393A GB 54597/66 A GB54597/66 A GB 54597/66A GB 5459766 A GB5459766 A GB 5459766A GB 1129393 A GB1129393 A GB 1129393A
- Authority
- GB
- United Kingdom
- Prior art keywords
- halo
- phenyl
- substituted
- tetrazolyl
- furyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002253 acid Substances 0.000 title abstract 6
- 150000007513 acids Chemical class 0.000 title abstract 4
- 125000003831 tetrazolyl group Chemical group 0.000 title abstract 3
- -1 heterocyclic aryl radical Chemical class 0.000 abstract 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000002541 furyl group Chemical class 0.000 abstract 3
- 125000004076 pyridyl group Chemical class 0.000 abstract 3
- 125000001544 thienyl group Chemical class 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229940100198 alkylating agent Drugs 0.000 abstract 2
- 239000002168 alkylating agent Substances 0.000 abstract 2
- 125000004494 ethyl ester group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 159000000001 potassium salts Chemical class 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960000380 propiolactone Drugs 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F23—COMBUSTION APPARATUS; COMBUSTION PROCESSES
- F23K—FEEDING FUEL TO COMBUSTION APPARATUS
- F23K3/00—Feeding or distributing of lump or pulverulent fuel to combustion apparatus
- F23K3/10—Under-feed arrangements
- F23K3/14—Under-feed arrangements feeding by screw
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Combustion & Propulsion (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51359965A | 1965-12-13 | 1965-12-13 | |
| US513553A US3412193A (en) | 1965-12-13 | 1965-12-13 | 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1129393A true GB1129393A (en) | 1968-10-02 |
Family
ID=27057915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB54597/66A Expired GB1129393A (en) | 1965-12-13 | 1966-12-06 | Tetrazolyl alkanoic acids |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3412193A (enExample) |
| BE (1) | BE691049A (enExample) |
| CH (1) | CH476001A (enExample) |
| DE (1) | DE1620057C3 (enExample) |
| FR (1) | FR1504326A (enExample) |
| GB (1) | GB1129393A (enExample) |
| NL (1) | NL6617500A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007502817A (ja) * | 2003-08-20 | 2007-02-15 | イーライ リリー アンド カンパニー | グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤 |
| US8552039B2 (en) | 2003-08-20 | 2013-10-08 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140242B (nl) * | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
| GB1192812A (en) * | 1966-05-20 | 1970-05-20 | American Cyanamid Co | 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts |
| US3597429A (en) * | 1968-02-15 | 1971-08-03 | Miles Lab | Derivatives of tetrazolyl alkanoic acids |
| GB1265866A (enExample) * | 1968-08-23 | 1972-03-08 | ||
| US3884922A (en) * | 1969-07-31 | 1975-05-20 | Yoshitomi Pharmaceutical | 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines |
| US4049809A (en) * | 1976-11-24 | 1977-09-20 | American Cyanamid Company | Solution of a oxazepine for oral or parenteral administration |
| GB1587128A (en) * | 1977-04-07 | 1981-04-01 | Hexachimie | Benzothiazepine derivatives |
| US5223497A (en) * | 1989-03-31 | 1993-06-29 | Yale University | Treating habit disorders |
| US5059600A (en) * | 1989-03-31 | 1991-10-22 | Yale University | Treating habit disorders |
| US5114942A (en) * | 1989-03-31 | 1992-05-19 | Yale University | Treating habit disorders |
| JP2002508323A (ja) * | 1997-12-17 | 2002-03-19 | メルク エンド カムパニー インコーポレーテッド | インテグリン受容体拮抗薬 |
| US6890919B2 (en) * | 2001-06-26 | 2005-05-10 | Shitij Kapur | Atypical antipsychotic agents having low affinity for the D2 receptor |
| US7388954B2 (en) * | 2002-06-24 | 2008-06-17 | Freescale Semiconductor, Inc. | Method and apparatus for tone indication |
| BR0317528A (pt) * | 2002-12-20 | 2005-11-22 | Basf Ag | Uso dos compostos, métodos para o controle de insetos, aracnìdeos ou nematodos, e para a proteção de plantas em crescimento contra o ataque ou a infestação por insetos, aracnìdeos ou nematodos, compostos, e, composições |
| EP1589974A2 (en) * | 2003-01-23 | 2005-11-02 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| PL1696931T3 (pl) | 2003-12-22 | 2009-10-30 | Acadia Pharm Inc | Aminopodstawione analogi diarylo[A,D]cykloheptenowe jako agoniści receptorów muskarynowych i sposoby leczenia chorób neuropsychiatrycznych |
| RU2006138497A (ru) * | 2004-04-01 | 2008-05-10 | Акадиа Фармасьютикалз Инк. (Us) | Кристаллические формы n-десметилклозапина |
| US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| PL2307389T3 (pl) * | 2008-06-20 | 2013-05-31 | Astrazeneca Ab | Pochodne dibenzotiazepiny i ich zastosowanie |
-
1965
- 1965-12-13 US US513553A patent/US3412193A/en not_active Expired - Lifetime
-
1966
- 1966-12-06 GB GB54597/66A patent/GB1129393A/en not_active Expired
- 1966-12-12 BE BE691049D patent/BE691049A/xx unknown
- 1966-12-12 FR FR87038A patent/FR1504326A/fr not_active Expired
- 1966-12-12 DE DE1620057A patent/DE1620057C3/de not_active Expired
- 1966-12-13 NL NL6617500A patent/NL6617500A/xx unknown
- 1966-12-13 CH CH1779166A patent/CH476001A/de not_active IP Right Cessation
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007502817A (ja) * | 2003-08-20 | 2007-02-15 | イーライ リリー アンド カンパニー | グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤 |
| US7947841B2 (en) | 2003-08-20 | 2011-05-24 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide |
| JP4754487B2 (ja) * | 2003-08-20 | 2011-08-24 | エミスフィアー テクノロジーズ インコーポレイテッド | グルカゴン様ペプチド（ｇｌｐ）−１化合物またはメラノコルチン４受容体（ｍｃ４）アゴニストペプチドの経口デリバリーのための化合物、方法および製剤 |
| US8546581B2 (en) | 2003-08-20 | 2013-10-01 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide |
| US8552039B2 (en) | 2003-08-20 | 2013-10-08 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
| US8765796B2 (en) | 2003-08-20 | 2014-07-01 | Emisphere Technologies, Inc. | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1620057A1 (de) | 1970-03-19 |
| FR1504326A (fr) | 1967-12-01 |
| DE1620057C3 (de) | 1978-06-08 |
| CH476001A (de) | 1969-07-31 |
| DE1620057B2 (de) | 1977-10-06 |
| US3412193A (en) | 1968-11-19 |
| NL6617500A (enExample) | 1967-06-14 |
| BE691049A (enExample) | 1967-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1129393A (en) | Tetrazolyl alkanoic acids | |
| SE7613651L (sv) | Sett att framstella fenylettiksyraderivat | |
| GB1456221A (en) | 3-hydroxy cephalosporins their ether derivatives and methods for their preparation | |
| ES412859A1 (es) | Un procedimiento para la preparacion de un derivado de 7- (alfa hidroxi-alfa-fenil) acetamido - 3 - (1 - metil - 1h - tetrazol - 5 - iltiometil) cefalosporina. | |
| GB1252329A (enExample) | ||
| ES397308A1 (es) | Un procedimiento para preparar esteres del acido mandeloil - aminocefalosporanico. | |
| ES368534A1 (es) | Procedimiento para la preparacion de nuevos derivados de laimidazolinona. | |
| FR2367045A1 (fr) | Preparation d'acides a-cetocarboxyliques aliphatiques et heterocycliques | |
| GB1438419A (en) | 2-oxo-1-pyridinyl penicillin and cephalosporin derivatives | |
| GB1138587A (en) | Improvements in or relating to photographic material | |
| ES399014A1 (es) | Procedimiento para la preparacion de derivados de acido 6-amino-penicilanico. | |
| JPS54112864A (en) | Novel imidazole derivative, its mineral acid salt, and their preparation | |
| GB1434757A (en) | Method and composition for the control of fertility | |
| ES385581A1 (es) | Procedimiento para la preparacion de derivados del acido 7-amino cefalosporanico. | |
| GB1252109A (enExample) | ||
| GB1284423A (en) | Cyclohexa-1,4-diene-1-acetic acids | |
| GB1319402A (en) | 3-acyloxypropyl-2,-trimethylammoniumethyl phosphates | |
| GB1341612A (en) | Theophylline isobutyrate salts and process for the preparation thereof | |
| ES483699A1 (es) | Un procedimiento para la preparacion del derivado acido 1h- indazol-3-ilacetico | |
| GB1266655A (enExample) | ||
| ES416456A1 (es) | Procedimiento para la preparacion de acidos 6 acilaminope- nicilanicos. | |
| ES377994A1 (es) | Procedimiento para la preparacion de nuevos derivados de imidazolidinona. | |
| ES420666A1 (es) | Procedimiento para preparar derivados de acidos (1-metil-5-nitro-2-imidazolil)tioalcanoicos. | |
| GB1248472A (en) | Cycloheptimidazolone derivatives and process for the preparation thereof | |
| GB1284019A (en) | Anticonvulsant compositions |